SHH:688278

Xiamen Amoytop Biotech Co., Ltd. · SHH · Healthcare · CNY · FY for 2025

Figures on this page computed 2026-11-08 13:48 UTC

Last close

n/aCNY

Market data

17.8xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed
- Computed from the filing for 2025
35.4%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
27.9%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
12.8%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.05Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed

6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

Follow one yuan

lens 1 of 9

After what it costs to make

93.0%

After running the business

33.5%

After interest and tax

27.9%

After what it must reinvest

12.8%

Kept after the dividend

6.0%

after what it costs to make, 93.0% of sales; after running the business, 33.5% of sales; after interest and tax, 27.9% of sales; after what it must reinvest, 12.8% of sales; kept after the dividend, 6.0% of sales

The five stops

5 of 5 read

After what it costs to make3,435,577,27093.0%
After running the business1,239,284,65533.5%
After interest and tax1,031,236,25227.9%
After what it must reinvest473,232,61012.8%
Kept after the dividend221,016,6106.0%

Of every unit of sales, 0.06 is still there after the dividend.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales3,695,567,867
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
After what it costs to make3,435,577,270
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
After running the business1,239,284,655
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
After interest and tax1,031,236,252
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
After what it must reinvest473,232,610
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Kept after the dividend221,016,610
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY